For a First In Human study, site activation and enrollment can present challenges, but when you add in investigator differences in opinions and team turnover, things can quickly get chaotic.
This case study will show you efficiencies and advanced benefits gained by having the expert and proactive full-service team at Cmed by your side, helping to differentiate your trial from all others.
Click here to see the case study: Cmed Early Phase Oncology Case Study_First In Human Study of an Antibody-Drug Conjugate in Breast Cancer
